9.85
+0.53
+(5.63%)
As of 3:03:28 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.2 | -0.2 | -0.2 | -0.21 |
| EPS Actual | -0.21 | -0.19 | -0.2 | -0.2 |
| Difference | -0.01 | 0.01 | 0 | 0.01 |
| Surprise % | -5.00% | 5.00% | 0.00% | 4.76% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GLSI | -- | -- | -- | -- |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/11/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/23/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/22/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy | 4/10/2023 |
Related Tickers
SLS SELLAS Life Sciences Group, Inc.
1.1300
+1.80%
ATOS Atossa Therapeutics, Inc.
0.6293
+6.73%
CMPX Compass Therapeutics, Inc.
1.6650
+0.91%
IMMP Immutep Limited
1.4407
+2.18%
INMB INmune Bio, Inc.
7.40
+9.96%
QURE uniQure N.V.
8.79
+2.51%
PRTA Prothena Corporation plc
10.22
+5.47%
FDMT 4D Molecular Therapeutics, Inc.
2.6150
+0.97%
BCTX BriaCell Therapeutics Corp.
4.2700
+6.75%
SWTX SpringWorks Therapeutics, Inc.
35.65
+3.54%